ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
60 hedge funds and large institutions have $70.5M invested in Zynerba Pharmaceuticals, Inc in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
28% more call options, than puts
Call options by funds: $10.7M | Put options by funds: $8.4M
Holders
60
Holding in Top 10
–
Calls
$10.7M
Puts
$8.4M
Top Buyers
| 1 | +$6.77M | |
| 2 | +$3.99M | |
| 3 | +$3M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.01M |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
+$1.99M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$380K | |
| 3 | -$372K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$218K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$181K |